CCL2 and asthma: In an inflammatory environment, the upregulation of CysLTR1 expression may increase monocyte sensitivity to cysteinyl leukotrienes (CysLTs), leading to the production of the potent chemokine CCL2, which promotes the aggregation of inflammatory cells in the airways and exacerbates asthma pathophysiology [67].